Keensight-backed Symeres snaps up Exemplify BioPharma
Exemplify BioPharma is Symeres’ second acquisition in the US this year.
Exemplify BioPharma is Symeres’ second acquisition in the US this year.
Copyright PEI Media
Not for publication, email or dissemination
